Volume 44, Issue 1, Pages 13-23 (February 2017) Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach Michele Boisdron-Celle, Olivier Capitain, Roger Faroux, Christophe Borg, Jean Philippe Metges, Marie Pierre Galais, Mehdi Kaassis, Jaafar Bennouna, Karine Bouhier-Leporrier, Eric Francois, Isabelle Baumgaertner, Véronique Guerin-Meyer, Oana Cojocarasu, Celia Roemer-Becuwe, Claire Stampfli, Ludovic Rosenfeld, Thierry Lecompte, Virginie Berger, Alain Morel, Erick Gamelin Seminars in Oncology Volume 44, Issue 1, Pages 13-23 (February 2017) DOI: 10.1053/j.seminoncol.2017.02.008 Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 1 Metabolic pathways of 5-fluorouracil. Seminars in Oncology 2017 44, 13-23DOI: (10.1053/j.seminoncol.2017.02.008) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 2 Distribution of DPD enzyme activity in a healthy population. Distribution of DPD enzyme activity in the 132 caucasian individuals tested in this study. The distribution differs significantly from Gaussian Normal and has significant positive skew and kurtosis [7]. Seminars in Oncology 2017 44, 13-23DOI: (10.1053/j.seminoncol.2017.02.008) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 3 Different SNPs in the hot spots of the DPYD gene. In red are shown the SNPs systematically screened in clinical practice. Seminars in Oncology 2017 44, 13-23DOI: (10.1053/j.seminoncol.2017.02.008) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 4 Study design. Seminars in Oncology 2017 44, 13-23DOI: (10.1053/j.seminoncol.2017.02.008) Copyright © 2017 Elsevier Inc. Terms and Conditions
Fig. 5 Survival probability of the two populations of patients without grade ≥3 toxic events (arm A: blue, arm B: red). Seminars in Oncology 2017 44, 13-23DOI: (10.1053/j.seminoncol.2017.02.008) Copyright © 2017 Elsevier Inc. Terms and Conditions